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Valerie B. O’Donnell2, Michael P. Philpott3 and Rebecca M. Porter1
Defolliculated (Gsdma3Dfl/þ ) mice have a hair loss phenotype that involves an aberrant hair cycle, altered
sebaceous gland differentiation with reduced sebum production, chronic inflammation, and ultimately the loss
of the hair follicle. Hair loss in these mice is similar to that seen in primary cicatricial, or scarring alopecias in
which immune targeting of hair follicle stem cells has been proposed as a key factor resulting in permanent hair
follicle destruction. In this study we examine the mechanism of hair loss in GsdmA3Dfl/þ mice. Aberrant
expression patterns of stem cell markers during the hair cycle, in addition to aberrant behavior of the
melanocytes leading to ectopic pigmentation of the hair follicle and epidermis, indicated the stem cell niche
was not maintained. An autoimmune mechanism was excluded by crossing the mice with rag1/ mice.
However, large numbers of macrophages and increased expression of ICAM-1 were still present and may be
involved either directly or indirectly in the hair loss. Reverse transcriptase-PCR (RT-PCR) and immuno-
histochemistry of sebaceous gland differentiation markers revealed reduced peroxisome proliferator-activated
receptor-g (PPARg), a potential cause of reduced sebum production, as well as the potential involvement of the
innate immune system in the hair loss. As reduced PPARg expression has recently been implicated as a cause for
lichen planopilaris, these mice may be useful for testing therapies.
Journal of Investigative Dermatology (2011) 131, 572–579; doi:10.1038/jid.2010.379; published online 16 December 2010
INTRODUCTION
Cicatricial alopecias, a group of hair loss disorders in humans
that involve the total destruction of the hair follicle (HF) with
associated inflammation, are also referred to as scarring
alopecias because of the replacement of the HF with
connective tissue (Somani and Bergfeld, 2008). In some,
such as lichen planopilaris (LPP), the sebaceous gland
appears atrophic because of either inflammation targeting
the gland or abnormal function. Defolliculated (Gsdma3Dfl/þ )
mice are one of several mouse mutations where a defective
sebaceous gland is associated with hair loss with similarities
to scarring alopecia. Gsdma3Dfl/þ share a similar phenotype
to other mice with a mutation in the gasdermin A3 (Gsdma3)
gene and to Asebia (Scd1ab2J) mice that have a defective
stearoyl CoA desaturase 1 (Scd1), an enzyme important in
lipogenesis in both the sebaceous gland and adipose tissue
(Zheng et al., 1999; Sundberg et al., 2000; Runkel et al.,
2004; Lunny et al., 2005; Tanaka et al., 2007). Similarities
include hair loss beginning at 4 weeks, HF destruction (8–15
weeks), chronic inflammation, and reduced lipid synthesis in
the sebaceous gland. In addition, the HF undergoes a
defective catagen, failing to complete regression (Porter
et al., 2002).
A number of hypotheses have been put forward to explain
the mechanism of HF destruction in cicatricial alopecias.
These include: (1) An autoimmune mechanism that not only
targets the HF but specifically damages or eliminates stem
cells of the bulge as a result of a collapse in immune privilege
(Karnik et al., 2009; Harries et al., 2010). (2) Interference in
dermal–epidermal signaling by the immune system. The HF
requires intricate epithelial–mesenchymal communication
between the dermal papilla and the stem cell niche to form
a follicle and to control the hair cycle. Hence, the immune
system may not necessarily interfere by physically damaging
cells but by producing signaling molecules that disrupt this
communication (McElwee, 2008). (3) Reduced sebaceous
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gland differentiation leading to reduced sebum synthesis. This
is believed to cause friction in the upper follicle so that, rather
than the hair shaft growing out of the follicle, the fiber is
forced backward frequently, leading to penetration and
damage of the outer root sheath (Sundberg et al., 2000). (4)
More recently, it has been shown that reduced expression of
peroxisome proliferator-activated receptor-g (PPARg), a
nuclear receptor (that acts as a transcription factor on ligand
binding), and altered lipid metabolism and peroxisome
biogenesis result in scarring alopecia (Harries and Paus,
2009; Karnik et al., 2009; Evers et al., 2010; Stenn and
Karnik, 2010). Moreover, these data showing a strong link
between lipid metabolism and scarring alopecia have also
led to the suggestion that alterations in lipid metabolism may
impact signaling. Altered lipid modification of proteins such
as hedgehogs and Wnts, which have a fundamental role in
HF homeostasis, may be a mechanism by which epithelial–-
mesenchymal signaling is disrupted (McElwee, 2008; Stenn
and Karnik, 2010). The aim of this study was therefore, to test
these hypotheses in GsdmA3Dfl/þ mice, thereby determining
the potential of these mechanisms for hair loss in humans.
RESULTS
Hair loss is not due to an autoimmune response in
Gsdma3Dfl/þ mice
The increased numbers of T cells suggested that an auto-
immune response could be a potential mechanism for HF
destruction in Gsdma3Dfl/þ mice (Porter et al., 2002). CD3,
a marker for all T cells, was immunolocalized to the
epidermis and infundibulum, as were gd T cells. This did
not change throughout the morphogenesis and destruction of
the HF. CD4, a marker for helper and regulatory T cells and
some innate immune cells, was prevalent in the dermis with a
few cells in the HF infundibulum and epidermis (Figure 1).
CD8-positive cells were not evident.
To investigate whether an autoimmune mechanism is
responsible for the phenotype, Gsdma3Dfl/þ mice were
crossed onto rag1/ mice that have a defect in the
recombinase-activating gene 1 leading to defective matura-
tion of T- and B-cell lymphocytes (Alt et al., 1992). Gross
appearance and histology compared at 8–15 weeks revealed
no differences in the timing or degree of HF destruction in
Gsdma3Dfl/þ rag1/ and Gsdma3Dfl/þ rag1þ /, indicat-
ing that T and B cells had no role in this process
(Supplementary Figure S1 online).
The stem cell niche is not maintained in aberrantly cycling HFs
Previously, we reported that Gsdma3Dfl/þ HFs undergo an
aberrant catagen stage where the follicle fails to regress
(Porter et al., 2002). This occurs at 17 days and at 7 weeks, as
summarized in the diagram in Figure 2. In this study we
report that at 8 weeks, the mutant mouse follicles re-enter a
second synchronized anagen phase. In contrast, in wild-type
mice the hair cycle is no longer synchronized with HFs
entering an extended telogen phase. HFs remain in the
anagen phase as they are eliminated with follicles that resist
destruction longest becoming aberrantly large (Figure 2).
Disruption of mesenchymal–epidermal communication is
highly possible in GsdmA3Dfl/þ mice, as during catagen,
the dermal papilla and bulge stem cell niche fail to come into
close proximity. As there is evidence that the immune system
may have a role in the hair cycle (Paus et al., 1998) and
cytokines may promote growth or inhibit apoptosis of
keratinocytes (Kemeny et al., 1994; Ruckert et al., 2000),
Gsdma3Dfl/þ rag1/ mice were also examined at 3–7 weeks.
Again, the phenotype of lymphocyte-deficient mice was
identical to Gsdma3Dfl/þ rag1/þ mice (Supplementary
Figure S1 online), indicating that T cells have no part in the
aberrant hair cycling.
Immunohistochemistry was carried out with a panel of
bulge stem cell markers Tcf3, Sox9, and CD34 (DasGupta
and Fuchs, 1999; Trempus et al., 2003; Vidal et al., 2005). In
wild-type mice, immunolocalization of CD34 to the mem-
branes of the bulge region was observed, but never at any
time from 3 to 8 weeks in Gsdma3Dfl/þ mice (Figure 3a and b).
Tcf3 was located in the nuclei of the bulge of wild-type mice
during telogen (Figure 3c) and also in the outer layer of the
Figure 1. T-cell subtypes in Gsdma3Dfl/þ mice. (a) The CD3 antibody gave
nonspecific reaction with the bulge (arrowhead) of the hair follicle (HF) in
wild-type mice as it was also observed in T-cell-deficient mice (not shown)
but (b) showed specific reactivity with T-cells in the epidermis and
infundibulum of the HF of Gsdma3Dfl/þ mice that (c) was depleted when
mice were crossed onto rag1/ background. (d) CD4-positive cells were
infrequent in wild-type mice and (e) found in large numbers, predominantly at
the dermal–subcutaneous boundary (arrow) with a few scattered cells in the
infundibulum of Gsdma3Dfl/þ mice. (f) gd T cells were absent in wild-type
mice and (g) immunolocalized to the epidermis and infundibulum in
Gsdma3Dfl/þ mice. Scale bar¼100 mm.
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outer root sheath in cells below the bulge in anagen (not
shown) as seen previously (DasGupta and Fuchs, 1999). In
Gsdma3Dfl/þ mice, Tcf3 was expressed normally in the
outer root sheath during anagen but expression was
completely lost from all regions of the catagen HF (Figure 3d).
At 4 weeks, as the Gsdma3Dfl/þ HFs are entering anagen,
Tcf3 is seen in the proximal follicle close to the dermal
papilla rather than the bulge (Figure 3f). Results with the Sox9
antibody were similar to Tcf3 (not shown).
We also examined the melanocytes in Gsdma3Dfl/þ mice
and observed that melanin, rather than being deposited solely
in the hair shaft, was in all the layers of the epidermis
immediately above the HF, in the outer and inner root
sheaths and in the dermal papilla (Figure 4). Ectopic
tyrosinase (an enzyme involved in melanin production)
activity in the outer root sheath and epidermis in
Gsdma3Dfl/þ was also detected, beginning during the first
hair cycle. Immunolocalization of melanocytes using Pax-3
as a marker for both stem cells and mature melanocytes
(Hornyak et al., 2001; Lang et al., 2005; Osawa et al., 2005)
suggested that this was due, in part, to migration of
melanocytes into the distal as well as in the proximal follicle
(Figure 4g).
Reduced sebocyte differentiation in GsdmA3Dfl/þ mice
Reduced sebum production is believed to be the cause of hair
shafts failing to exit the follicle smoothly, leading to damage
to the HF and chronic inflammation (Sundberg et al., 2000). If
this is the case, then the preputial gland, which is also
affected by reduced sebum production, should be devoid of
inflammation. Comparing the preputial gland of wild-type
and Gsdma3Dfl/þ mice by immunohistochemistry with the
immune cell markers MAC-1 and CD3, we observed
infiltration of macrophages (Supplementary Figure S2 online)
but not T cells.
Reverse transcriptase-PCR (RT-PCR) of sebocyte differen-
tiation markers revealed a decrease in Scd1 and Scd3 in
GsdmA3Dfl/þ mouse skin (Figure 5). Immunohistochemistry
of Scd1 showed expression in the subcutaneous layer as in
wild-type mice but the sebaceous gland rarely showed any
immunoreactivity. However, on the rare occasion when Scd1
expression was observed, the sebaceous gland also produced
sebum. C/EBPa was unchanged and C/EBPb appeared to be
still present in the nucleus of GsdmA3Dfl/þ sebocytes by
immunohistochemistry (not shown). PPARa and PPARg
transcription was reduced at all stages of the hair cycle,
and immunohistochemistry confirmed the loss of expression
of PPARg in the sebaceous gland (Figure 5).
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Figure 2. Stages of the hair cycle in Gsdma3Dfl/þ compared with wild-type
(WT) mice. (a) Diagram to compare the hair cycle of Gsdma3Dfl/þ mice with
WT C57Bl/6 mice (2–9 weeks). Gsdma3Dfl/þ mice undergo two aberrant
catagen stages at 17 days and 7 weeks. Anagen and the second catagen are
slightly delayed compared with WT mice. The hair follicles (HFs) enter a
synchronized second anagen at 8 weeks, during which HF deletion takes
place. (b) At 10 weeks, HFs that have not been deleted can become aberrantly
large in Gsdma3Dfl/þ . Scale bar¼200 mm.
Figure 3. Stem cell markers are absent in Gsdma3Dfl/þ . (a) CD34
immunolocalized to the hair follicle (HF) bulge in wild-type (a0 at
higher magnification) follicles but (b) no immunolocalization to the upper
follicle was observed in Dfl/þ rag1/ mice. (c) In telogen, Tcf3 is located
in the bulge of wild-type mice but (d) is lost from HFs of Gsdma3Dfl/þ mice
during the aberrant catagen. (e) At 4 weeks, follicles re-enter anagen in
wild-type and show Tcf3 in the bulge, but (f) in Gsdma3Dfl/þ mice the Tcf3 is
restricted to the proximal follicle close to the dermal papilla. Scale
bars¼ 50 mm in a–c; 20mm in a0; and 100 mm in d–f.
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Chronic inflammation is likely to be because of reduced
PPARc expression in the sebaceous gland
Reduced expression of PPARg as an underlying cause of LPP
is the most recent hypothesis put forward (Karnik et al.,
2009). The mechanism proposed is via peroxisome depletion
and production of proinflammatory lipids in response to
increased 5-lipoxygenase and cyclooxygenase-2 activity. In
both LPP and a conditional PPARg knockout mouse, there is
increased activation of macrophages and T cells. The number
of macrophages is also extremely high in the dermis of
Gsdma3Dfl/þ mice, and at 4 and 8 weeks these were also
highly concentrated in the subcutaneous layer (Figure 6). The
phenotype was identical when crossed onto the rag1/
background. However, RT-PCR and western analysis of
cyclooxygenase-2 shows no increase in expression in
Gsdma3Dfl/þ mice, and RT-PCR of Pex3 does not support
a decrease in peroxisome activity (not shown). Analysis of
lipids extracted from Gsdma3Dfl/þ mice also showed no
increase in arachidonic acid or prostaglandins. However, an
increase in 12-hydroxyeicosatetraenoic acid (12-HETE) was
observed, suggesting increased 12-lipoxygenase activity
(Supplementary Figure S3 online).
In wild-type animals, ICAM-1expression was observed
occasionally around HFs as observed previously (Eichmuller
et al., 1998), but was upregulated in Gsdma3Dfl/þ rag1þ /
and in Gsdma3Dfl/þ rag1/ mice. This was not solely
restricted to HFs but also found strongly expressed in the
basal layer of intrafollicular epidermis and in dermal cells
(Figure 6c and d).
DISCUSSION
Crossing Gsdma3Dfl/þ with rag1/ eliminates a lympho-
cyte-driven autoimmune mechanism but does not rule out an
innate immune response. Macrophages were also present in
the mice crossed with rag1/. Although these macrophages
are clearly not being activated by lymphocytes, natural killer
cells, which are not depleted, are also capable of activating
macrophages in the absence of T cells (Bancroft and Kelly,
1994; Feng et al., 2006), and may have a role in the hair loss
phenotype seen in Gsdma3Dfl/þ mice. Programmed organ
deletion by macrophages targeting the stem cells has
been proposed as a potential mechanism for HF deletion
(Eichmuller et al., 1998). Although macrophages are present
in Gsdma3Dfl/þ mice, they do not appear to cluster speci-
fically around the bulge but are located throughout the
dermis and sometimes in the subcutaneous layer. ICAM-1
expression was also found to be generally expressed around
HFs and epidermis rather than clustered in the bulge region,
suggesting that macrophages are not targeting the HF
specifically. As activated macrophages have multiple roles
both in injury and remodeling of tissues (Gordon, 2003), it is
difficult to determine the exact role of macrophages in
Gsdma3Dfl/þ mice without depleting them. The same can
also be said of mast cells that are also activated in these mice
(Porter et al., 2002).
The evidence shown here indicates depletion of bulge
stem cell markers, but it is not clear when this happens. CD34
is not normally expressed in the bulge until after the first
telogen (Blanpain et al., 2004), and Sox9/Tcf3 are found in
the proximal follicle during morphogenesis and anagen
(DasGupta and Fuchs, 1999; Vidal et al., 2005). Therefore,
the loss of these markers in the stem cell niche cannot be
monitored before the first catagen/telogen when CD34
expression is switched on and Sox9/Tcf3 become restricted
to the bulge. It is not possible, therefore, to be sure if they are
depleted by the immune system gradually before this or
because of the aberrant hair cycle causing reduced signaling
between the dermal papilla and stem cell niche. However,
the fact that the pelage HFs are capable of a precocious
Figure 4. Aberrant location of mature pigment-producing melanocytes.
(a) Melanin is found in the inner root sheath and hair shaft (b) in all layers of
the epidermis above the hair follicle (HF) and (c) in the outer root sheath.
(d) From the surface of the skin, melanin is confined to the region surrounding
the hair shaft (arrowheads). (e) Tyrosinase activity (green) indicates pigment
formation in the outer root sheath and epidermis. (f) Pax 3-positive nuclei
can be seen in the outer root sheath high up in the infundibulum and
epidermis (arrowheads) as well as in the bulb. Scale bars¼ 20mm in a–c;
50mm in d and e; and 100mm in f.
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synchronized anagen at 8 weeks does not imply that they are
being subjected to immune damage. If chronic inflammation
was the cause of stem cell deletion, then a gradual deletion
of Tcf3/CD34-positive cells would be expected rather than
a complete absence of Tcf3/CD34 immunoreactivity in the
stem cells at 3 weeks seen here.
Reduction in CD34 expression has been associated with
a loss of stem cell quiescence and can occur independently
of expression of other stem cell markers (Rhee et al., 2006;
Kobielak et al., 2007). This is consistent with the inability
of the follicles to enter telogen and the precocious anagen
at 8 weeks. Tcf3 is a member of the Tcf/Lef family of
DNA-binding proteins that bind to b-catenin on Wnt
signaling. However, Tcf3 in the bulge appears to have a
b-catenin-independent role in inhibiting stem cell differentia-
tion (Nguyen et al., 2006). Therefore, loss of Tcf3 could have
serious consequences for maintenance of the HF stem cell
niche.
Along with the relatively quiescent bulge, there is also a
pool of stem cells in the HF secondary germ that resides
proximal to the bulge in close proximity to the dermal papilla
in telogen follicles (Panteleyev et al., 2001; Ito et al., 2004).
These cells divide first at the beginning of anagen. The HF
predetermination hypothesis proposes that these cells are
destined to become the inner root sheath and hair shaft of the
next anagen follicle and move down in close proximity to the
dermal papilla as a ‘‘lateral disc’’ (Panteleyev et al., 2001).
The outer root sheath meanwhile is proposed to be derived
from the bulge stem cells. Although not all HF labeling
experiments support this hypothesis (Legue et al., 2010),
there may be some truth in the persistence of hair germ-
derived cells residing in close proximity to the dermal papilla,
as Tcf3 expression returns to cells in the proximal follicle first
at the beginning of anagen in Gsdma3Dfl/þ mice.
Normally, the melanocyte stem cells divide at the
beginning of anagen and progeny (melanoblasts) migrate
from the bulge down the outer root sheath, only differentiat-
ing into mature melanocytes to pigment the developing hair
shaft when in close proximity to the dermal papilla (Slominski
et al., 2005). The aberrant migration and ectopic pigmenta-
tion by the melanocytes in Gsdma3Dfl/þ may therefore also
be evidence that catagen/telogen is essential for maintaining
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Figure 5. Sebaceous gland differentiation markers. (a) Reverse transcriptase-PCR (RT-PCR) of back (or tail) skin was carried out at different stages of the
hair cycle and hair follicle (HF) loss. d, days; D, Gsdma3Dfl/þ ; t, tail; w, weeks; W, wild-type. (b) Immunolocalization of stearoyl CoA desaturase 1 (Scd1)
is highly expressed in wild-type mice in the center of the gland but (c) is absent in most sebaceous glands of Gsdma3Dfl/þ mice. (d) Peroxisome
proliferator-activated receptor-g (PPARg) (red) is present in the nuclei of the outermost cells of the sebaceous gland in wild-type but (e) not in Gsdma3Dfl/þ
mice. Green indicates intracellular lipids. Scale bar¼ 50 mm.
Figure 6. Increase in macrophages in the skin. (a) In wild-type animals,
occasional macrophages were observed but (b) in Gsdma3Dfl/þ mice
macrophages were frequently observed in large numbers in the dermis.
(c) ICAM-1 expression was occasionally seen in wild-type mice around
the hair follicle (HF) but (d) was found around all the HFs in Gsdma3Dfl/þ
mice, in the basal epidermis and in the cells of the dermis. Scale
bars¼ 100mm in a and b and 50mm in c and d.
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the undifferentiated state of cells in the stem cell niche.
However, pigment transfer and localization of melanocytes
has been shown to be controlled by the epithelial cells
(Weiner et al., 2007; Aubin-Houzelstein et al., 2008).
There is some controversy regarding the role of PPARg in
lipid synthesis in the sebaceous gland. In monolayer cultures
of sebocytes, PPAR agonists stimulate lipogenesis (Trivedi
et al., 2006), whereas treatment of the intact gland inhibits
sebum production (Downie et al., 2004). Scd1 has been
shown to contain a PPAR response element in its promoter
(Miller and Ntambi, 1996), and hence the lack of PPARg and
Scd1 in the sebaceous glands of Gsdma3Dfl/þ mice does
point toward a role for PPARg in promoting lipogenesis in the
sebaceous gland. However, PPARg depletion in the HF stem
cells (Karnik et al., 2009) leads to atrophic sebaceous glands
rather than abnormal differentiation as observed in
Gsdma3Dfl/þ mice. Although PPARg is ablated in the stem
cells, the effect of PPARg ablation is unlikely to be on the
stem cells themselves, as PPARg has been shown to be
inhibited in the bulge by Tcf3 (Nguyen et al., 2006).
Moreover, it is not clear if PPARg is also depleted in the
sebaceous gland by the methods used by Karnik et al. (2009).
Increased macrophage accumulation and hair loss have
been observed in PPARg-deficient mice (Karnik et al., 2009)
and in pups nursed by PPARg-deficient mothers because of
proinflammatory lipids produced in the milk (Wan et al.,
2007). In both these cases, and in LPP, the inflammation
seems to be because of proinflammatory lipids produced
from arachidonic acid by cyclooxygenase-2, which is not the
case in Gsdma3Dfl/þ mice. Although this suggests that
Gsdma3Dfl/þ mice are not a model for LPP, there was some
patient–patient variation reported when the differentially
expressed genes identified by microarray analysis of 20
pooled LPP cases were compared individually (Karnik et al.,
2009). There may therefore be several mechanisms for LPP,
and lipid analysis of patients should include 12-HETE.
The macrophage infiltration into the preputial gland in
GsdmA3Dfl/þ strongly points toward dysregulation of lipid
synthesis as the underlying cause of chronic inflammation, as
damage by the hair shaft can be excluded in this tissue.
PPARg is expressed in the outermost dividing cells of the
sebaceous gland, whereas GsdmA3 is expressed in the most
differentiated cells at the center. This suggests communi-
cation between differentiated cells and dividing cells. Indian
hedgehog is expressed in the most differentiated cells and has
been shown to control proliferation but not differentiation of
basal cells by a paracrine mechanism (Niemann et al., 2003).
However, no reduction in expression of Indian hedgehog in
GsdmA3Dfl/þ mice was observed. GsdmA3 may be capable
of affecting the differentiation of the basal cells in a paracrine
manner or may cause other factor(s) to be released during the
holocrine secretion of lipids. As the PPARg ligand is believed
to be a fatty acid, the latter is perhaps more likely.
In conclusion, the phenotype of GsdmA3Dfl/þ mice
shares many aspects in common to LPP, including reduced
sebum production, chronic inflammation, scarring alopecia,
and, as shown here, a reduced expression of PPARg. What is
not clear is whether the aberrant catagen stage is also likely to
be a common characteristic with LPP. Whereas in mice the
hair cycle is short and synchronized, the human scalp HFs
have a hair cycle that is asynchronous with an anagen stage
that takes 6–8 years compared with a catagen stage that takes
weeks (Saitoh et al., 1970). Therefore, the majority of follicles
are in anagen and a defect in catagen could be overlooked.
Mutations in GsdmA3 are unlikely to be the underlying cause
of LPP, as the incidence of LPP is higher in women and the
GsdmA3Dfl mutation affects both sexes equally. However,
these mice have a useful role because, unlike the recently
generated model for LPP with ablation of the PPARg gene,
they are capable of responding to treatment that restores
PPARg activity. Although stimulation with PPARg agonists is
counterintuitive when the level of expression of PPARg is low
or absent, Mirmirani and Karnik (2009) have successfully
treated one LPP patient with pioglitazone. Reversal of the
phenotype in GsdmA3Dfl/þ mice would prove that PPARg
agonists can restore PPARg activity despite low levels of
expression, and would strengthen the argument for clinical
trials for their use in the treatment of LPP as well as providing
a model for testing future-generation drugs.
MATERIALS AND METHODS
Mice
Defolliculated (original symbol: Dfl) mice are heterozygous for a
spontaneous mutation in the Gsdma3 gene and are therefore
designated the symbol Gsdma3Dfl/þ (Porter et al., 2002; Lunny
et al., 2005). Mice were crossed with C57BL/6J (Harlan, UK,
Loughborough, UK) to generate Gsdma3Dfl/þ and wild-type
controls and housed in scantainers to maintain specific pathogen-
free conditions. Rag1/ mice have a defect in the recombinase-
activating gene-1 leading to defective V(D)J recombination (Alt
et al., 1992), and are therefore immune compromised, requiring
breeding in an isolator. First round of breeding generated Gsdma3Dfl/þ
rag1þ / mice identified by their hairless phenotype. These were
then bred again onto rag1/ mice to generate all genotypes
including Gsdma3Dfl/þ rag1/ mice. Rag1/ mice were identi-
fied by the absence of T cells either by flow cytometry using
fluorescently labeled antibodies TCR-PE, CD4-PE-Cy3, and CD8-APC
(BD-Pharmingen, Oxford, UK) or by immunohistochemistry of
spleen sections (see below). All mouse studies were approved by
the Cardiff University ethical review panel and in compliance with
UK Home Office regulations.
RT-PCR analysis of sebocyte differentiation markers
Complementary DNA was synthesized from RNA (1 mg) extracted
with Trizol (Invitrogen, Paisley, UK) from full-thickness dorsal or tail
skin using AMV reverse transcriptase (Promega, Southampton, UK)
and oligo-dT. See Supplementary Table S1 online for PCR primers.
Immunohistochemistry and immunofluorescence
Full-thickness skin was dissected from the upper dorsal surface or tail
of GsdmA3Dfl/þ mice and wild-type littermates at time points from
2 to 15 weeks. Preputial glands were collected from male mice (6–8
weeks). Paraffin-embedded samples underwent antigen retrieval.
Frozen sections (5–10 mm) were fixed in dried acetone or 4%
paraformaldehyde (15minutes). Primary antibodies (dilutions in
Supplementary Table S2 online) were incubated for 1 hour or
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overnight. Biotinylated secondary antibodies (1:200; GE Healthcare
UK, Little Chalfort, UK) and streptavidin-conjugated horseradish
peroxidase (1:100; GE Healthcare UK) were incubated for 30minutes
at room temperature. Immmunofluorescence was carried out using
Alexa Fluor 594 (1:500; Invitrogen) and intracellular lipids were
labeled with Bodipy 493/503 (Invitrogen) 1:500 of a 1mgml–1
stock in ethanol. The tyrosinase assay was performed as described
(Han et al., 2002).
Lipid extraction and HETE quantification using liquid
chromatography/tandem mass spectrometry
Full-thickness mouse skin was homogenized under liquid nitrogen in
the presence of butylatedhydroxytoluene and diethylenetriamine-
pentacetic acid to prevent artifactual oxidation. The homogenate
was then extracted using hexane/iso-propanol/acetic acid. The
extracted lipids were then evaporated to dryness and re-suspended
in 100ml methanol before liquid chromatography/tandem mass
spectrometry analysis. Samples were separated on a C18 Spherisorb
ODS2, 5 mm, 150 4.6mm column (Waters, Herts, UK) using a
gradient of 50–90% B over 10minutes (A, water/acetonitrile/acetic
acid, 75:25:0.1; B, methanol/acetonitrile/acetic acid, 60:40:0.1)
with a flow rate of 1mlmin1. Products were quantitated by liquid
chromatography/electrospray ionization/tandem mass spectrometry
on an Applied Biosystems 4000 Q-Trap using parent to daughter
transitions of m/z 319.2 (HETE, [M-H]) to m/z 179 (12-HETE), 115
(5-HETE), 155 (8-HETE), 167 (11-HETE), 219 (15-HETE), andm/z 327
to 184 for 12-HETE-d8, with collision energies of 20 to 30V.
Products were identified and quantified using HETE positional
isomers and 12-HETE-d8 standards run in parallel.
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